| Profile | GDS1873 / 202169_s_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 596.586 | 79 |
| GSM40788 | control - Rep 2 | 460.704 | 75 |
| GSM40789 | control - Rep 3 | 542.57 | 79 |
| GSM40775 | androgen treated - Rep 1 | 281.56 | 64 |
| GSM40776 | androgen treated - Rep 2 | 459.643 | 75 |
| GSM40777 | androgen treated - Rep 3 | 522.599 | 78 |
| GSM40790 | estrogen treated - Rep 1 | 366.366 | 70 |
| GSM40791 | estrogen treated - Rep 2 | 595.691 | 80 |
| GSM40792 | estrogen treated - Rep 3 | 635.53 | 81 |
| GSM40784 | A + tamoxifen - Rep 1 | 393.732 | 71 |
| GSM40785 | A + tamoxifen - Rep 2 | 563.848 | 79 |
| GSM40786 | A + tamoxifen - Rep 3 | 557.712 | 79 |
| GSM40778 | A + anastrozole - Rep 1 | 285.189 | 64 |
| GSM40779 | A + anastrozole - Rep 2 | 652.35 | 81 |
| GSM40780 | A + anastrozole - Rep 3 | 475.651 | 76 |
| GSM40781 | A + letrozole - Rep 1 | 210.214 | 55 |
| GSM40782 | A + letrozole - Rep 2 | 637.317 | 81 |
| GSM40783 | A + letrozole - Rep 3 | 663.29 | 82 |